This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Alembic Limited. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Kishore Khemani: Innovator in Pharmaceutical Chemistry
Introduction
Kishore Khemani is a notable inventor based in Vadodara, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of processes for drug preparation. His work has implications for the treatment of various medical conditions, showcasing his commitment to innovation in healthcare.
Latest Patents
Khemani holds a patent for a process related to the preparation of Rivastigmine. This invention involves an improved method for synthesizing Rivastigmine or its pharmaceutically acceptable salts. The process includes a step of N-methylation of a specific compound using paraformaldehyde in the presence of Raney Nickel and hydrogen in a suitable solvent. This innovative approach enhances the efficiency of producing this important pharmaceutical compound.
Career Highlights
Khemani is associated with Alembic Limited, a prominent pharmaceutical company known for its research and development in drug formulation. His role at Alembic Limited has allowed him to contribute to various projects aimed at improving drug efficacy and safety. His expertise in pharmaceutical processes has been instrumental in advancing the company's product offerings.
Collaborations
Khemani has worked alongside talented colleagues such as Pandurang Balwant Deshpande and Bharat Becharbhai Boda. These collaborations have fostered a creative environment that encourages innovation and the sharing of ideas within the pharmaceutical sector.
Conclusion
Kishore Khemani's contributions to pharmaceutical chemistry, particularly through his patent for Rivastigmine preparation, highlight his role as an innovator in the industry. His work continues to impact the field positively, demonstrating the importance of research and development in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
